Nucleic acids and proteins from streptococcus groups A and B

Details for Australian Patent Application No. 2002214127 (hide)

International Classifications

Event Publications

8 July 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee from Chiron Srl to Chiron S.r.l.

7 June 2007 Application Accepted

Published as AU-B-2002214127

4 October 2007 Standard Patent Sealed

5 February 2009 Alteration of Name

The name of the patentee has been altered to The Institute for Genomic Research; Novartis Vaccines and Diagnostics S.r.l.

18 February 2010 Assignment Registered

Novartis Vaccines and Diagnostics S.r.l.; The Institute for Genomic Research The patent has been assigned to Novartis Vaccines and Diagnostics S.r.l.; J. Craig Venter Institute ,Inc.

1 December 2011 Assignment Registered

J. Craig Venter Institute ,Inc.; Novartis Vaccines and Diagnostics S.r.l. The patent has been assigned to J. Craig Venter Institute, Inc.; Novartis Vaccines and Diagnostics, Inc. Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.